Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CENTENE CORPORATION

(CNC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Centene Settles With Ohio, Mississippi to Resolve Pharmacy-Unit Claims

06/14/2021 | 05:28am EDT

By Dave Sebastian

Centene Corp. said it has reached no-fault agreements with the attorneys general of Ohio and Mississippi to resolve the states' claims related to services provided by the company's pharmacy-benefits manager unit, Envolve Pharmacy Solutions Inc.

The health insurer on Monday said it would pay $88 million to Ohio and $55 million to Mississippi under the agreements. Practices described in the settlement focus on the structure and processes of Envolve mainly during 2017 and 2018, the company said. Centene said it denies liability for any of the practices.

The Ohio attorney general's litigation against the company would be dismissed as part of the settlement, Centene said.

Centene said it is in discussions with a plaintiff's group led by law firms Liston & Deas and Cohen Milstein Sellers & Toll PLLC to bring final resolution to the concerns in other affected states. The company said it has recorded a reserve estimate of $1.1 billion related to the issue, exclusive of the settlements.

Write to Dave Sebastian at dave.sebastian@wsj.com

Corrections & Amplifications

This item was corrected on June 15, 2021 to show that the name of law firm Cohen Milstein Sellers & Toll PLLC was abbreviated as Cohen Milstein.

(END) Dow Jones Newswires

06-14-21 0728ET

All news about CENTENE CORPORATION
07/30CENTENE : Announces Offering of Senior Notes (Form 8-K)
PU
07/30CENTENE CORP : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
07/29CENTENE CORPORATION : Prices Offering of Senior Notes
PR
07/29CENTENE CORPORATION : Announces Offering of Senior Notes
PR
07/28CENTENE : 2021 outlook grows murky for insurers as COVID-19 surges
AQ
07/27Global markets live: LVMH, Michelin, Tesla, Amazon, Activision...
07/27Today on Wall Street: Tech’s big day
07/27CENTENE : Reports Lower Q2 Adjusted EPS, Higher Revenue
MT
07/27CENTENE : REPORTS SECOND QUARTER 2021 RESULTS (Form 8-K)
PU
07/27CENTENE : Q2 Earnings Snapshot
AQ
More news
Financials (USD)
Sales 2021 124 B - -
Net income 2021 1 440 M - -
Net Debt 2021 9 280 M - -
P/E ratio 2021 28,6x
Yield 2021 -
Capitalization 40 003 M 40 003 M -
EV / Sales 2021 0,40x
EV / Sales 2022 0,39x
Nbr of Employees 71 300
Free-Float 96,0%
Chart CENTENE CORPORATION
Duration : Period :
Centene Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CENTENE CORPORATION
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 20
Last Close Price 68,61 $
Average target price 86,03 $
Spread / Average Target 25,4%
EPS Revisions
Managers and Directors
Michael F. Neidorff Chairman, President & Chief Executive Officer
Andrew Lynn Asher Chief Financial Officer & Executive Vice President
Mary V. Mason Chief Medial Officer & Senior Vice President
Ken Yamaguchi Chief Medical Officer & Executive Vice President
Mark J. Brooks Chief Information Officer & Executive VP
Sector and Competitors
1st jan.Capi. (M$)
CENTENE CORPORATION14.29%40 003
UNITEDHEALTH GROUP17.55%389 013
ANTHEM, INC.19.70%93 628
CIGNA CORPORATION10.24%78 748
HUMANA INC.4.99%54 725
MOLINA HEALTHCARE, INC.20.00%15 944